Key result
TriageTrue whole blood hs-cTnI matches Vitros assay accuracy with 100% NPV for MI rule-out.
Why the study?
Point-of-care testing and triage liaison physicians could help alleviate emergency department overcrowding, prompting evaluation of the diagnostic performance of a point-of-care hs-cTnI assay for rapid myocardial infarction rule-out.
Does the TriageTrue point-of-care hs-cTnI assay provide comparable diagnostic accuracy to the Vitros 3600 assay for ruling out myocardial infarction in the emergency department?
Observational (n=225)
Does the TriageTrue point-of-care hs-cTnI assay provide comparable diagnostic accuracy to the Vitros 3600 assay for ruling out myocardial infarction in the emergency department?
A single measurement using the TriageTrue point-of-care hs-cTnI assay provides a 100% negative predictive value for ruling out myocardial infarction, offering a rapid alternative for ED triage.
Supports ED point-of-care troponin testing; leaves open need for prospective outcome validation before practice change.
Background Point-of-care (POC) testing and triage liaison physicians could help alleviate the impact of emergency department (ED) overcrowding. The aim of our study was to evaluate the diagnostic performance of the TriageTrue POC assay for the rapid rule-out of myocardial infarction based on a single measurement of high-sensitivity cardiac troponin I (hs-CTnI). The diagnostic performance was compared to measurements obtained with the Vitros 3600 assay, taking into account the cutoffs recommended by the European Society of Cardiology. Methods The study compared results of troponin obtained simultaneously on the TriageMeterPro device from whole blood and plasma samples (n = 139) and the hs-cTnI assay on the Vitros 3600 instrument from EDTA plasma samples (n = 225). The diagnostic performance of the 3 methods was compared, including negative predictive value and sensitivity as well as positive predictive value and specificity. Concordance between the methods with disease state samples was then assessed using the Cohen kappa test. Results An excellent correlation between plasma and whole blood samples was achieved with the TriageTrue with a coefficient of correlation >0.99 and a bias of +8.2 (±45, with 95% CI 0.4 to 16.0) ng/L. A significant overestimation (around 47%) of the values obtained with the TriageTrue compared with those of the Vitros was also observed. Our results confirmed the acceptable and comparable diagnostic accuracy to the established hs-cTnI-Vitros assay, with a negative predictive value of 100% to rule-out myocardial infarction. Conclusion Our results demonstrated that the TriageTrue hs-cTnI whole blood test could serve as an alternative method for ruling out or confirming non-ST-elevation myocardial infarction in the prehospital setting using a single POC troponin measurement.
No takes yet. Share an insight, caveat, or question.
Dupuy et al. (2026) conducted an observational in myocardial infarction (n=225). TriageTrue POC assay vs. Vitros 3600 assay was evaluated on negative predictive value to rule-out myocardial infarction. The TriageTrue hs-cTnI whole blood test demonstrated a negative predictive value of 100% to rule-out myocardial infarction, showing comparable diagnostic accuracy to the established Vitros assay.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: